Blog

Fast-growing Breakout Agency Brings Bold Creative and Deep Insights-Driven Approach to Global Healthcare Clients

SAN FRANCISCO & NEW YORK–(BUSINESS WIRE)–W2O, the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector, today announced the acquisition of 21GRAMS, a rapidly growing, strategic and creative marketing, advertising and patient/medical education agency dedicated to making healthcare more human.

The transformative acquisition will further strengthen W2O’s creative firepower and expand its capabilities in direct-to-consumer (DTC), direct-to-provider (DTP) and business-to-business (B2B) advertising and marketing to support the rapidly changing needs of the healthcare industry. 21GRAMS brings a differentiated method of fundamentally understanding a healthcare brand’s audience to ultimately make advertising less of an interruption and more worth their time, attention and action, while also offering a comprehensive suite of bold creative content capabilities. Together, W2O and 21GRAMS are committed to breaking down walls between the disciplines of advertising, marketing, communications and medical education to ensure a fully connected, inspiring and meaningful experience for patients, physicians and the entire healthcare ecosystem.

“21GRAMS is a true innovator, offering something different and more profound than its competitors. The agency’s philosophy that the work can and should tap into the human spirit, inspiring the invisible ‘something’ inside, aligns directly with our patient-first ethos and to what we are doing for clients. The unique strengths of 21GRAMS immediately enhances what we’ve been building over the last few years at W2O, a truly integrated approach to marketing communications. From my days as a client, I’ve always believed in the strength of a multi-disciplinary team spanning advertising, digital, branding, media activation and engagement working together in unison to deliver optimal business results,” said W2O Founder and CEO Jim Weiss. “Together, we will combine our experienced, results-oriented teams, integrating the best in proprietary data and analytics, creative content, and omnichannel activation to create a next-generation entity that’s equal parts technology and science – providing clients with a level of expertise that compares more to Netflix or Google than any network that currently exists. Simply put, we are joining together to be the first at ‘what’s next’ in health.”

This acquisition also bolsters W2O’s position in medical and scientific communications, as 21GRAMS has a robust medical and patient education division that will complement the three recent W2O acquisitions of Arcus MedicaISO.health and Radius Digital Science. This will allow for deeper engagement with healthcare influencers, which is critical to W2O’s bench to bedside approach. W2O works with more than 100 healthcare companies, from innovative start-ups to 24 of the 25 largest global pharmaceutical companies as well as some of the leading payors and providers.

“W2O has been leading the charge in health’s tech revolution, combining intelligence with the latest technology to provide an unfair advantage for brands and organizations – not at the speed our industry is accustomed to, but in real-time to elevate the overall value and relevance of healthcare marketing and communications in today’s chaotic, digital-first world,” said Robert Blink, Founder and CEO of 21GRAMS. “Joining this like-minded and forward-thinking organization gives us greater scale, as well as significant technological innovation and global reach – allowing us to match our ambitions to our abilities. Together, we are designing the future in health, connecting humanity and technology to position healthcare brands as more inspiring than sneakers, fast food or soda water.”

Over the last several years, W2O has significantly expanded and strengthened its overall portfolio, including its advertising and digital capabilities. Having curated a team of more than 200 of the industry’s leading professionals, W2O has been producing and executing innovative, award-winning marketing programs fueled by the organization’s proprietary data analytics platform. This approach measures success based on the impact it’s had on a client’s business performance. 21GRAMS adds more than 150 advertising and patient/medical education specialists to the W2O family. With extensive experience in working with healthcare brands across all major therapeutic areas and developmental stages, 21GRAMS’ core capabilities include advertising (direct-to-consumer and healthcare provider), patient storytelling, medical education, strategy, analytics and television production.

“Together, these powerful complementary forces put us in a more capable and competitive position than ever before to address the commercialization challenges and opportunities of our global clients,” added Weiss.

The 21GRAMS brand, approach and leadership team will operate under W2O’s single, integrated profit and loss (P&L) operation, with access to all of W2O’s proprietary data models and tools as well as it’s 1,000 person strong multidisciplinary team – including data analysts, scientific strategists, branding experts, communications specialists and creatives – to build unfair advantage for clients and their brands. Additionally, the 21GRAMS leadership team will remain the same with Robert Blink, Wendy LevineJayson Dupré and Frank Mazzola.

21GRAMS and W2O are privately held companies and the financial terms of the acquisitions are not being disclosed. A team from Excel Partners, led by Ed Soh and Doug Donohue, served as the exclusive financial advisor to 21GRAMS.

About 21GRAMS

21GRAMS was built to be different by design, fusing advertising and education for the first time in an agency model. As two arms of the same body, these disciplines work seamlessly, to inject creativity into education and give advertising exclusive and personal access to doctors and patients – providing an unmatched ability to uncover deeper insights and create work that truly “gets” them. Using brands people love as a model for connecting with audiences, 21GRAMS adheres to the mantra “Medicine should be more inspiring than sneakers.” Obsessing less on minutia, and more on what makes people tick. For more information, visit 21GRAMSNY.com.

About W2O

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. W2O maintains 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

Contacts

W2O
Sylvia Aranda, 424-201-9464
saranda@w2ogroup.com

Read More
Tags:

SAN FRANCISCO – W2O, the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector, today announced that veteran biopharmaceutical executive Jonathan Peacock and distinguished advertising and digital marketing expert George Gallate have joined its board of directors. The appointments are intended to guide W2O’s accelerated growth plans to meet the evolving needs of its healthcare clients in a digital world and on an international scale.

Peacock has more than three decades of C-suite experience in the pharmaceutical, emerging biotech and corporate financial industries. He has held global chief financial officer (CFO) roles at Novartis and Amgen, as well as leadership positions in strategy and corporate finance at McKinsey & Company and PricewaterhouseCoopers. Gallate is rejoining the W2O board of directors. He has more than 30 years of experience in building and leading high-performing global and regional advertising and digital networks. As the former Global CEO and then Chairman of digital marketing agency giant Havas Digital, Gallate helped build the company into one of the largest digital networks globally.

“Jon and George are powerful additions to our board as we take our business to the next level to become a partner of choice for clients focused on becoming more relevant and competitive in a digital world,” said Jim Weiss, W2O Founder and CEO. “Jon has a proven track record of steering operations, strategy and business development for two of the world’s leading biopharmaceutical companies, and George has built one of the largest digital agency networks globally and guided agency alliances and partnerships with some of the world’s leading technology companies, such as Amazon and Google. Their respective insight and unmatched expertise will serve as a true asset and help guide us as we strategically build our talent pool and expand our capabilities to achieve our mission of making the world a healthier place through marketing and communications.”

During Peacock’s tenure at Amgen, the company’s share price increased by approximately 125%. While serving as CFO at Novartis Pharma, he helped increase the company’s operating profit by 40%. From 2014 to 2017, he served as Audit and Finance Committee Chair at Kite Pharma until its sale to Gilead for $11.9 billion in 2017. Following his time at Havas, Gallate served as the CEO of RKG, an independent search agency focused on the intersection of search and social, facilitating substantial revenue growth for the company throughout his tenure. He also negotiated the company’s sale to Merkle in 2014, where he then successfully served as Chief Marketing Officer for several years.

“W2O certainly lives up to its reputation of being one of, if not the most, diversified and dynamic healthcare marketing and communications firms in the industry. I continue to be impressed by the firm’s talent and use of analytics and technology to understand the evolving and ever-changing needs of healthcare companies,” said Peacock.

“As healthcare organizations and brands continue to look for new models to connect with patients, healthcare professionals and customers, W2O has distinguished itself as a premier firm when it comes to integrating analytics, creative, technology and activation skillsets into a unified delivery model that ultimately provides clients with the most high-value, breakthrough marketing and communications solutions,” said Gallate.

In June, W2O announced a new partnership with New Mountain Capital to drive growth and strengthen its relationship with clients throughout the healthcare spectrum. Since then, the company has made three acquisitions in the field of scientific and medical marketing communications and plans to pursue additional acquisitions to expand both its offerings and geographic presence.

The firm will continue to expand and enhance its board of directors, bringing in more diverse and differentiated expertise to expand its portfolio and talent.

About W2O 

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. W2O maintains 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

Contact

W2O

Peter Duckler, 773-343-3069

pduckler@w2ogroup.com

Read More
Tags:

SAN FRANCISCO AND MONTCLAIR, N.J. – W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced the acquisition of Radius Digital Science,  an award-winning scientific digital creative agency. Radius offers a differentiated service to the healthcare industry, fusing art and technology to translate complex science into immersive, easy-to-understand creative experiences for healthcare brands.

This acquisition is the latest in a series designed to expand and deepen W2O’s scientific marketing communications offering, which will organize and brand as W2O Science. Radius, which will now operate as W2O radius, adds nearly 25 scientifically trained, tech-savvy creative strategists to the W2O family.  Radius co-founders Michelle Peterson and Brandon Pletsch will serve in leadership roles within this business unit, which will be part of W2O’s single profit and loss (P&L) operation.

Combining Radius with W2O’s existing staff in this area along with that of recently acquired scientific communications and medical marketing firms ISO.health (now W2O iso) and Arcus Medica (now W2O arcus), W2O Science is now more than 100 people strong, including 18 doctoral level experts and 25 scientific creative strategists throughout the United States and Europe.

“We were already partnering successfully with Radius to bring our clients’ science to life through more dynamic and impactful digital media and evocative artistic expression,” said W2O Founder and CEO Jim Weiss. “Formally joining forces with this highly respected digital science powerhouse further diversifies our extensive ‘marketeching’ toolbox and raises the bar for how we execute on scientific creative across our suite of integrated capabilities.”

Headquartered in Montclair, N.J., Radius brings new science-based, digital creative capabilities to W2O, including medical illustration and 3D animation, molecular visualization, UX design and programming, experiential media, and creative execution for scientific congresses and tradeshows.

“In our experience of working closely with W2O, we’ve always been impressed with their ability to deliver highly targeted, impactful narratives, and the ability to tailor those messages to specific audiences,” said Pletsch, Partner, W2O radius. “Complementing that kind of industry insight with cutting edge, digitally-driven visual design that breaks down the complexities of the science is going to help us amplify a brand’s potential in ways we’ve never seen before.”

With experience across a broad range of disease categories and healthcare specialties, Radius has built a solid reputation among its client base as a solutions-oriented, strategic thought partner that can translate high-science into digestible, visually stimulating digital content. Whether it is building an iPad app that explains a disease, creating animations that show how a medical therapy works or producing a digital infographic that provides guidance for patients, the company has become a partner of choice for healthcare innovators looking to better position science as core to their relevance. Radius’ seasoned team will both complement and enhance W2O’s scientific and medical marketing communications offering and high-science advertising agency-of-record (AOR) platform.

“We are methodically evolving as a firm to achieve our vision to improve healthcare through marketing communications,” added Weiss. “We plan to do that by elegantly balancing the art and science these new firms bring to us and our clients. As our clients ask us to do more, we add the capabilities they expressly need and want. By integrating these specialized teams with our proprietary data analytics, already robust scientific strategy capabilities and integrated PR and advertising expertise, W2O places science at the epicenter of our offerings. This is all designed to strengthen the power, authenticity and differentiation of our clients’ narratives and build greater trust in their brands.”

Radius and W2O are privately held companies, and the financial terms of the acquisitions are not being disclosed. Nisivoccia, LLP, and Lum, Drasco & Positan, LLC acted as financial advisors to Radius in the transaction. 

About Radius Digital Science

Founded by Michelle Peterson and Brandon Pletsch in 2014, Radius Digital Science is a creative agency dedicated in equal measure to expert-level scientific strategy and visually-stunning, innovative digital experiences.

About W2O

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. W2O maintains 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

Read More
Tags:

SAN FRANCISCO AND LONDON – W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced the acquisition of ISO.health, continuing its global expansion in scientific and medical marketing communications. ISO. comprises a talented team of industry experts who are adept at developing and delivering impactful omni-channel medical and scientific educational programs for pharmaceutical, biotech and life sciences companies and organizations.

“With healthcare brands having a predominantly international audience, the importance of leading with science is essential as it represents the backbone of a brand’s global narrative. ISO. is exceptionally capable at translating often highly complex data into insightful, effective language with relevant media and that reaches and resonates with multiple stakeholders across geographies,” said Jim Weiss, W2O founder and CEO. “This symbiotic partnership will enable us to provide more far-reaching support for our clients.”

ISO. brings a robust European-based scientific and medical communications arm to W2O, along with a well-established and synergistic client base. With extensive experience in working with healthcare companies across all major therapeutic areas and stages of development, ISO.’s core capabilities include strategic and operational planning, stakeholder mapping, opinion leader development, advisory board management, scientific narration, event conceptualization and management, disease awareness programming, data release planning and digital integration. The combination of ISO. and W2O will create a leader in scientific marketing communications on an increasing international scale, offering significant market growth opportunities in both Europe and the United States.

Last month, W2O acquired Philadelphia-based scientific and medical communications agency Arcus Medica (now W2O arcus) to bolster its growing high-science marketing communications discipline. The addition of ISO. to the W2O roster further cements W2O’s focus on placing science at the epicenter of its expansive marketing communications platform, ensuring the organization delivers the best integrated solutions that empower its clients throughout every stage of their lifecycle.

“Together we are building a global leader in analytics-driven medical and scientific marketing communications,” added Weiss.

ISO. will operate as W2O iso in W2O’s global brand architecture, with co-founders Suzanne Jacobs, Oli Burnham and Isabel Gibson serving in leadership roles within this business unit. The team will work together with additional multidisciplinary teams across the organization, harnessing science, strategy and innovation to deliver powerful results for clients.

“Since our company’s inception, our primary focus has centered on looking through the lens of healthcare professionals, patients and advocacy groups to develop holistic medical communications campaigns, rooted in science, that drive real value to our clients. W2O thrives on an analogous approach – giving brands a distinctive advantage by marketing science to deliver the most impactful stories,” said Jacobs, Partner, W2O iso. “We are thrilled to join this forward-thinking organization to create a next-level, geographically diverse offering that surpasses all expectations.”

ISO. and W2O are privately held companies, and the financial terms of the acquisitions are not being disclosed. Wright Vigar acted as exclusive financial advisor to ISO. in the transaction.

About ISO.health

Founded by Suzanne Jacobs, Oli Burnham and Isabel Gibson in 2016, ISO.health is a London-based medical communications agency with the belief that science makes the difference. It’s where cures come from and where value is created. It’s where we start. It’s what we love.

About W2O

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. W2O maintains 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

# # #

Read More
Tags:

W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced the acquisition of Arcus Medica. A recognized leader in medical and scientific communications, Arcus brings a deep bench of doctoral-level experts to W2O who specialize in translating complex clinical and scientific data into clear, meaningful content to help brands influence key audiences in today’s evolving healthcare environment.

This acquisition represents a vital move by W2O to disrupt the status quo in medical and scientific communications by creating a fully integrated communications agency that uses proprietary data and analytics to fuel scientific strategy, peer-to-peer medical engagement and patient-centered narration for clients. Given the highly complex and fragmented nature of the healthcare industry, companies and their brands require data-informed insights and clear, compelling storytelling to drive value. W2O and Arcus share a passion for uncovering deep scientific acuities to build best-in-class strategy and deliver high quality communications that resonate.

“Arcus is a trailblazer in the field of medical and scientific communications, consistently following the data to get to the right outcome for its clients. The addition of Arcus to the W2O family significantly enhances our medical and scientific communications expertise and enriches our offering in this key discipline,” said Jim Weiss, W2O founder and CEO. “Together, we will continue to place science at the center of everything we do, supplementing this prowess with unmatched data analytics and insights, robust strategy and creative know-how to ensure we deliver maximum impact to client business, from the bench to the bedside.”

With the integration of Arcus, W2O’s scientific and medical communications team will comprise approximately 40 best-in-class employees, including 16 doctoral level experts. Arcus co-founders Mary Seideman, MD, PhD, Stan Eapen, PharmD, and Jonathan Seideman, PhD, will all serve in leadership roles at W2O arcus, which will be an integral part of W2O’s single profit and loss (P&L) operation. These tenured industry experts, along with their seasoned team of communicators, will work closely with W2O’s scientific strategy team run by Ujwal Pyati, PhD, and other multidisciplinary teams across the company – including data analysts, brand strategists, creatives and media specialists – to drive differentiated communications and meet diverse client objectives.

“We founded Arcus on the premise of serving as strategic partners to our clients by providing world-class communications attuned to the unique challenges of the healthcare market. We couldn’t be more excited about our affiliation with W2O, given Jim and his team’s commitment to becoming the best by understanding every client’s business and treating it as its own, delivering the highest quality work and results and applying data analytics to every program it touches,” said Mary Seideman, Partner, W2O arcus. “Our partnership is genuinely symbiotic, and we look forward to working together to achieve something truly great for our dynamic clients and remarkable people.”

Earlier this year, W2O announced its partnership with New York based investment firm New Mountain Capital, enabling the company to support continued growth and accelerated scaling to meet the evolving needs of its clients in an increasingly digital and data-centric world. The partnership will take W2O to the next level of talent, capability, geographic and technology expansion to serve clients better and more expansively than ever while maintaining the independent, entrepreneurial spirit upon which the company was founded.

“At W2O we actively listen to our clients and continually enhance our capabilities based on what they ask for and what we foresee them needing to move their business forward,” Weiss added. “Integrating Arcus’ scientific and medical communications capability into our expansive, multidisciplinary service offering will ensure we are more competitively positioned and favored in the healthcare communications marketplace, ultimately enabling us to meet the changing demands of our clients and provide our people with greater career growth opportunities.”

Both companies are privately held, and the financial terms of the acquisition are not being disclosed. Delancey Street Partners acted as exclusive financial advisor to Arcus in the transaction.

About Arcus Medica

Arcus Medica prides itself on being strategic partners to its clients. The company’s deep scientific expertise in multiple disease areas allows for flawless delivery of world-class communications attuned to the unique challenges of today’s drug market. Arcus pairs extensive in-house industry experience with agency know-how to translate complex clinical and scientific data into clear and meaningful content.

About W2O

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. W2O maintains 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

Read More
Tags:

San Francisco, June 12, 2019 – W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced that it has closed its previously announced investment partnership deal with New Mountain Capital.

“This partnership will allow us to achieve our mission of making the world a healthier place through marketing communications,” said Founder & CEO Jim Weiss. “We will invest to become the very best we can be, building our talent, technology and capabilities to serve our clients better and more expansively than ever – strategically, executionally, and geographically – all while maintaining our independent, entrepreneurial culture and spirit.”

About New Mountain Capital

New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $20 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit www.newmountaincapital.com.

About W2O 

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing services and communications to the healthcare sector.  W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. W2O maintains 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

# # #

Read More
Tags:

Company primed for next level of international, talent, capability and technology expansion to meet evolving needs of healthcare stakeholders in a digital world 

San Francisco, May 29, 2019 – W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced it has partnered with New Mountain Capital to accelerate continued growth and scale of the company to meet the evolving needs of its clients to most effectively and efficiently communicate with and influence their key stakeholders in an increasingly digital and mobile world.

The current W2O management team will remain in place, and both Jim Weiss, W2O Founder and CEO, and Jennifer Gottlieb, W2O President, will serve on the board of directors. The transaction is expected to close in the first half of W2O’s fiscal year 2019, subject to customary approvals and closing conditions. Current investment partner Mountaingate Capital is exiting W2O in the transaction. CG Petsky Prunier, part of the Canaccord Genuity Group, and Houlihan Lokey served as financial advisors to W2O and Mountaingate Capital. Financial terms were not disclosed.

In 2016, W2O partnered with Mountaingate to fund the firm’s strategic growth plans, which included three acquisitions – Pure Communications, Marketeching and Sentient – in addition to hiring key talent and making focused investments to expand and enhance its highly integrated technology and service offerings. Since that time, the firm’s revenues more than doubled from just under $100 million annually in 2016 with just over 400 people to anticipated revenues of more than $200 million in 2019 with nearly 800 people.

“We achieved in three years what we planned to do in five, so we were looking for a new partner that could help us maintain our momentum while preserving our dynamic, entrepreneurial culture that provides consistent career growth, innovation, and learning and development opportunities for our people,” said Weiss. “New Mountain is the right partner for this next inflection point in our evolution, one that aligns with an inflection point in healthcare as the sector continues to be impacted by technology at an unprecedented pace. Working with New Mountain, we will continue building and acquiring talent and companies with capabilities that clients have told us they need and want, and facilitate expansion in key markets overseas and in the U.S.”

“This partnership enables us to continue to control our own destiny and pursue our goal of ‘Becoming the Best’ for our clients, and to achieve a renewed mission to make the world a healthier place through marketing communications,” said Gottlieb. “There’s nothing more important than your health, and the future leaders in healthcare will be those that can communicate and compete most effectively in a mobile and digital world through both traditional and non-traditional media channels guided by next-generation analytics. We will not only continue to build and model our business to help our clients achieve this, but also become a digital health player in our own right.”

“W2O is a true leader in healthcare marketing, communications and analytics. We are excited to partner with Jim and his amazing team to support their next phase of growth as a key player in the evolution of the segment,” said Matt Holt, Managing Director at New Mountain Capital. “Healthcare is just beginning to discover new forces in medicine, prevention and cures, and W2O is participating with leading client organizations throughout the healthcare continuum. Our partnership is meant to support investments in key areas while enabling W2O to maintain its successful entrepreneurial culture, commitment to innovation, and unmatched client focus.”

According to Bruce Rogers, Managing Director of Mountaingate Capital, which initially partnered with W2O on this growth strategy, “W2O and its team exceeded our expectations in every way, successfully assimilating acquisitions, on-boarding talent and delivering data-driven insights to inform strategy and programming to achieve a competitive advantage for clients. This is a stellar team committed to client excellence, employee experience and development, and elevating the healthcare ecosystem. We are very pleased to see W2O advance to its next phase of growth with New Mountain Capital and wish Jim and the team the best for continued success.” 

Mountaingate Capital

Mountaingate Capital is a private equity firm based in Denver that specializes in building and empowering companies with strong growth potential and engaged leadership teams. Mountaingate’s focus on organic growth coupled with its proven customer-centric buy-and-build approach for add-on acquisitions and shared equity ownership with management creates more value for the end customer, while forging stronger, more collaborative, and more successful investment partnerships with management teams. Mountaingate targets investments in new platform companies typically with $5 million to $25 million of EBITDA. For more information on Mountaingate, please visit http://mountaingate.com.

About New Mountain Capital
New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $20 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit www.newmountaincapital.com.

About W2O 

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing services and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. W2O maintains 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

 # # #

Contact:
W2O
Peter Duckler, 310-774-3425
pduckler@w2ogroup.com

Read More
Tags:

New York, April 11, 2019 – W2O Group, an innovative, analytics-driven, digital-first marketing and communications firm, today released its 2018 Relevance Index of Fortune 100 companies. Launched in 2017, the Relevance Index is a proprietary analytics model designed to determine the relevance of companies in multiple industries as it relates to stakeholder engagement in a social/digital reality. The Index tracks specific signals related to CEO approval, financial analyst coverage, employee visibility, search and the marketplace to determine the level of relevance for an organization or brand.

The 2018 Relevance Index found that Facebook, Google, Delta Airlines, Walt Disney, Apple, Costco and Amazon scored highest, mainly replicating their 2017 rankings. These companies displayed strong alignment of internal and external narratives, differentiating thought leadership, innovation-oriented cultures and agile interaction with key stakeholders. This year, Goldman Sachs and JP Morgan were new additions to the list.

The firm will also release its first-ever Healthcare Relevance Index in approximately two weeks.

“Relevance is the new reputation,” said Gary Grates, Principal at W2O. “It provides a more actionable measure for leaders to determine if they are truly connecting with key audiences – interests, concerns, beliefs, expectations – and if this connection is resulting in greater engagement with the organization. The Index not only captures relevance, it also illuminates what a company needs to do from a decision and action standpoint to help it achieve a bold and differentiating narrative.”

Following are key findings from the 2018 Relevance Index of leading Fortune companies, which is available in full at https://w2o.to/2018RelevanceIndex

A summary of the 2018 Relevance Index:

  • Only 8 percent of Fortune 100 companies registered a strong or resilient relevance.
  • 51 percent of companies registered as susceptible or weak, suggesting their relevance is highly vulnerable and they need to take significant, immediate, clear, genuine and sustained actions to engage with stakeholders who matter on the topics that matter to them.
  • Among the relevance leaders, drivers were positive recommendations from financial analysts, high CEO approval ratings, and high search interest (despite much lower news sharing).
  • Leaders:
    • Have a clear, consistent, differentiating narrative, POV, thought leadership are bold, nimble, attuned and ahead
    • Are Proactive:  bold statements and innovation-centric announcements drive relevance (see Goldman Sachs Crypto currency example on slide 10)
    • Understand the Trump factor:  responses to Trump statements (both critique and praise) are drivers of relevance
  • Companies that fall in the middle of the Index have low content sharing and low search interest, apathetic stakeholders, and incongruencies in internal and external scores (narratives, understanding, support, outlook, advocacy). Additionally, they experience challenges due to leadership changes, organizational flux or plateaus, and M&A activity.

“In 2018, we found it was easier for Fortune 100 companies to lose than gain relevance,” said Chuck Hemann, Managing Director, Analytics. “It’s critical that companies truly comprehend stakeholders in a deep manner as a foundation to engagement. Organizations can often lose sight of stakeholders in today’s fast-moving environment, missing the originality and impact needed to gain relevance. In 2018, eight of the top 15 relevance organizations were the same as 2017 albeit movement in terms of score. This indicates the fluidity of relevance and, for companies, necessitates a more disciplined effort to stay attuned and stay ahead.”

About W2O’s Relevance Index

Launched in 2017, W2O’s Relevance Index ranks the top Fortune 100 organizations on how they perform from an engagement and interaction standpoint. The Index tracks specific signals related to CEO approval, financial analyst coverage, employee visibility, search and the marketplace to determine the level of relevance for an organization or brand. The aggregate number provides a relevance score indicating where an organization or brand performs vis-à-vis its competitive set. The model reflects actual observed behavior vs. reported perceptions.

About W2O

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing services and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. The firm employs nearly 800 people in 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

# # #

Contact:

W2O

Peter Duckler, 310-774-3425

pduckler@w2ogroup.com

Read More
Tags:

Digital-first marketing and communications firm keeping ahead of curve by evolving capabilities, attracting and developing talent, and designing solutions for clients seeking unfair advantage

San Francisco, March 5, 2019 – W2O, an innovative, analytics-driven, digital-first marketing and communications firm, reported a 23 percent increase in revenue to $177 million in 2018 from $144 million in 2017. The company also increased its profit margin by a similar amount.

Since its founding in 2001 by healthcare communications executive Jim Weiss, W2O has distinguished itself by investing in the future specifically in the areas of data analytics and insights, digital and social media, content creation, and activation and strategic consulting. Over 150 of W2O’s clients actively use its analytics platform. This pioneering approach has set the firm apart and allows its hundreds of professionals to transcend traditional boundaries by connecting multiple components of the marketing, digital and communications mix. They weave this all together to partner with a growing roster of Fortune 500 clients, including 24 of the top 25 pharmaceutical companies, to create and deploy integrated solutions that measurably impact business results.

“In looking at 2018, the headline is this: Great Clients + Great People = Great Results,” said Founder and CEO Jim Weiss. “Putting all that aside, our results are a reflection of being strong partners with our clients – proactive in our thinking, responsive in our service, and strategic in our capabilities. We are always working hard to punch above our weight because we are on a mission to improve healthcare and the patient experience through strategic marketing and communications by achieving clarity, understanding and engagement.”

During 2018, the firm:

  • Launched the Relevance Health Index, an extension of its Relevance Model and Index covering the Fortune 500 and its engagement in a social/digital reality
  • Expanded its Market Access and Value & Pricing teams with the addition of new members and research offerings
  • Started our Scientific and Medical Communications group
  • Opened three new offices – in Atlanta, Washington, D.C. and Zurich
  • Supported 29 U.S. Food and Drug Administration product approvals
  • Designed, built and launched over 100+ corporate websites
  • Completed 2,200 analytics and research projects
  • Conducted 160+ executive and media coaching sessions, including with dozens of CEOs

The firm also strengthened its board of directors and senior leadership team with the addition of the following individuals:

  • George Gallate, W2O Board Member – formerly Chief Marketing Officer at Merkle, Global Chairman at Havas Worldwide Digital, and Regional CEO at Euro RSCG Asia Pacific
  • Deborah Hankin, Chief People Officer – a senior HR professional from a marketing and consultancy background with a diverse set of recruiting and talent development skills
  • Keri P. Mattox, Global Lead of Integrated Corporate Communications – formerly Vice President, Corporate & Investor Relations, at Amerisource Bergen, a Fortune 10 company
  • Hsiao Liu, Global Practice Leader – formerly Executive Vice President at Ogilvy Health and an integrated marketing leader focused on Asia Pacific market expansion

“It’s always been about delivering results for clients as they navigate their way through complex times. 2018 was another banner year for us with numerous new client wins across the pharma, biotech, payer/provider and digital health space, along with creating a larger, more integrated team across 15 offices,” said Jennifer Gottlieb, President of W2O. “In 2019, we will grow our global presence and mindset, invest in key expertise and portfolios, expand our PESO (paid, earned, shared and owned) media capability and offerings, extract insights from our ever-expanding and deepening data ingestion engine and combinatorial views from our qual and quant research approach, and hone operational efficiency, customer service and delivery.”

Additional notable accomplishments for W2O over the last 12 months include the following:

  • Won 150+ awards, including:
    • AdAge’s Best Places to Work 2019
    • The Holmes Report’s Best Agency to Work for 2018 (Large)
    • MM&M’s Best Places to Work 2018
    • MM&M and Holmes Report Large Agency of the Year (Finalist)
    • Jim Weiss was selected for the PharmaVOICE 100
    • Jennifer Gottlieb was inducted into the Hall of Femme 2018
    • Andy Boothe, Senior Director, Data Sciences, was named to the Holmes Report’s Innovator 25 list
  • Jim Weiss was appointed to the Healthcare Businesswomen’s Association (HBA) Global Board of Advisors
  • Angela Gillespie, President of W2O wcg, was appointed to the HBA’s 2019 Global Board of Directors and serves on the Executive Committee as secretary/treasurer
  • Entered its seventh year in partnership with Syracuse University for the W2O Center for Social Commerce at the Newhouse School, which is considered the premier industry-academic partnership model
  • Continued to invest in an innovative diversity healthcare communications effort with The LAGRANT Foundation. The partnership includes fellowships, in-office trainings and Jim Weiss’s seat on the LAGRANT board.
  • Served as lead sponsor of a Signature Research Study with IPR – The Future of Work – exploring technology, artificial intelligence (AI) and generational workforces on the state of organizational effectiveness
  • Rolled out Springboard, a leadership development program for W2O employees who are account director level and above and have been with the company for at least two years

“Every year since we began has been a year of transformation and learning,” added Weiss.

“We’ve never rested on our laurels and continually challenge ourselves and our clients to do better, to see what’s not in front of us, to dig deeper for the best approach, and to ignore labels and descriptions. It’s the W2O Way, and it won’t ever change.”

About W2O

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing services and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. The firm employs nearly 800 people in 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

# # #

Contact:

W2O

Peter Duckler, 310-774-3425

pduckler@w2ogroup.com

Read More
Tags: